Stock listing
Frankfurt:EAJF ValiRx PLC Aktie
German listing (Frankfurt) of ValiRx PLC · home listing LSE:VAL
Follow ValiRx PLC into a list and get an email when it puts out news.
Home listing price · LSE:VAL
0.14p GBX (pence) -0.00 (-3.4%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, LSE:VAL
- Day range
- 0.135p – 0.15p GBX (pence)Nov 20, 2026
- Volume
- 31.27M sharesNov 20, 2026
- Market cap
- £1.85M GBPAt the close on Nov 20, 2026 · price × 1.32B shares outstanding
- 52-week range
- 0.12p – 0.48p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- £24,871 GBPMedian day 3.87M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:VAL · Home | 0.14p GBX (pence) | -0.005 (-3.4%) | 31,274,077 | 0.147p | 0.15p | 0.135p | 0.145p | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:VAL · GBX (pence), adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.14p | -0.005 | -3.4% | 0.147p | 0.15p | 0.135p | 31,274,077 | |
| 0.145p | -0.005 | -3.3% | 0.152p | 0.152p | 0.14p | 6,660,254 | |
| 0.15p | +0.01 | +7.1% | 0.133p | 0.16p | 0.13p | 25,916,243 | |
| 0.14p | -0.015 | -9.7% | 0.16p | 0.16p | 0.135p | 14,331,913 | |
| 0.155p | -0.005 | -3.1% | 0.15p | 0.156p | 0.15p | 1,260,091 | |
| 0.16p | 0.00 | 0.0% | 0.159p | 0.17p | 0.143p | 12,244,976 | |
| 0.16p | -0.01 | -5.9% | 0.18p | 0.18p | 0.15p | 31,296,629 | |
| 0.17p | +0.03 | +21.4% | 0.142p | 0.18p | 0.134p | 36,284,105 | |
| 0.14p | 0.00 | 0.0% | 0.13p | 0.15p | 0.13p | 3,761,521 | |
| 0.14p | -0.005 | -3.4% | 0.14p | 0.15p | 0.13p | 5,473,163 | |
| 0.145p | -0.015 | -9.4% | 0.16p | 0.16p | 0.14p | 29,093,903 | |
| 0.16p | -0.01 | -5.9% | 0.172p | 0.18p | 0.15p | 6,449,058 | |
| 0.17p | 0.00 | 0.0% | 0.18p | 0.18p | 0.16p | 1,297,396 | |
| 0.17p | 0.00 | 0.0% | 0.164p | 0.18p | 0.16p | 10,824,070 | |
| 0.17p | 0.00 | 0.0% | 0.177p | 0.20p | 0.16p | 51,713,648 | |
| 0.17p | +0.03 | +21.4% | 0.147p | 0.18p | 0.13p | 95,414,368 | |
| 0.14p | +0.005 | +3.7% | 0.135p | 0.15p | 0.13p | 20,712,516 | |
| 0.135p | 0.00 | 0.0% | 0.14p | 0.14p | 0.13p | 5,080,360 | |
| 0.135p | -0.005 | -3.6% | 0.13p | 0.15p | 0.13p | 12,359,989 | |
| 0.14p | 0.00 | 0.0% | 0.145p | 0.15p | 0.13p | 19,686,788 | |
| 0.14p | -0.005 | -3.4% | 0.145p | 0.15p | 0.132p | 22,248,986 | |
| 0.145p | -0.015 | -9.4% | 0.175p | 0.21p | 0.14p | 318,842,015 | |
| 0.16p | +0.03 | +23.1% | 0.13p | 0.19p | 0.121p | 151,517,717 | |
| 0.13p | 0.00 | 0.0% | 0.13p | 0.13p | 0.12p | 3,869,934 | |
| 0.13p | 0.00 | 0.0% | 0.13p | 0.135p | 0.12p | 1,475,119 | |
| 0.13p | 0.00 | 0.0% | 0.13p | 0.14p | 0.12p | 732,183 | |
| 0.13p | 0.00 | 0.0% | 0.13p | 0.14p | 0.12p | 47,551 | |
| 0.13p | -0.005 | -3.7% | 0.135p | 0.15p | 0.121p | 949,497 | |
| 0.135p | 0.00 | 0.0% | 0.135p | 0.15p | 0.12p | 3,739,550 | |
| 0.135p | 0.00 | 0.0% | 0.135p | 0.15p | 0.12p | 3,778,756 | |
| 0.135p | 0.00 | 0.0% | 0.135p | 0.15p | 0.12p | 179,965 | |
| 0.135p | 0.00 | 0.0% | 0.135p | 0.15p | 0.12p | 1,664,378 | |
| 0.135p | 0.00 | 0.0% | 0.135p | 0.15p | 0.121p | 34,698 | |
| 0.135p | 0.00 | 0.0% | 0.135p | 0.15p | 0.123p | 3,004,457 | |
| 0.135p | 0.00 | 0.0% | 0.135p | 0.15p | 0.12p | 969,096 | |
| 0.135p | 0.00 | 0.0% | 0.135p | 0.15p | 0.12p | 900,905 | |
| 0.135p | +0.01 | +8.0% | 0.125p | 0.138p | 0.12p | 6,149,045 | |
| 0.125p | 0.00 | 0.0% | 0.125p | 0.13p | 0.122p | 776,850 | |
| 0.125p | 0.00 | 0.0% | 0.125p | 0.13p | 0.123p | 4,208,795 | |
| 0.125p | 0.00 | 0.0% | 0.125p | 0.13p | 0.122p | 1,141,054 | |
| 0.125p | -0.005 | -3.8% | 0.13p | 0.14p | 0.12p | 20,128,568 | |
| 0.13p | -0.005 | -3.7% | 0.135p | 0.14p | 0.13p | 4,096,960 | |
| 0.135p | 0.00 | 0.0% | 0.135p | 0.14p | 0.13p | 1,002,959 | |
| 0.135p | -0.005 | -3.6% | 0.14p | 0.15p | 0.13p | 5,326,975 | |
| 0.14p | 0.00 | 0.0% | 0.14p | 0.15p | 0.132p | 1,838,972 | |
| 0.14p | -0.005 | -3.4% | 0.145p | 0.15p | 0.131p | 9,541,460 | |
| 0.145p | 0.00 | 0.0% | 0.145p | 0.145p | 0.14p | 701,976 | |
| 0.145p | 0.00 | 0.0% | 0.145p | 0.15p | 0.13p | 2,161,415 | |
| 0.145p | 0.00 | 0.0% | 0.145p | 0.15p | 0.141p | 11,488,627 | |
| 0.145p | 0.00 | 0.0% | 0.145p | 0.15p | 0.141p | 984,654 | |
| 0.145p | 0.00 | 0.0% | 0.145p | 0.15p | 0.14p | 1,686,659 | |
| 0.145p | 0.00 | 0.0% | 0.145p | 0.15p | 0.14p | 7,262,324 | |
| 0.145p | +0.005 | +3.6% | 0.14p | 0.15p | 0.13p | 7,029,585 | |
| 0.14p | 0.00 | 0.0% | 0.14p | 0.148p | 0.132p | 6,022,000 | |
| 0.14p | 0.00 | 0.0% | 0.14p | 0.15p | 0.13p | 1,327,913 | |
| 0.14p | 0.00 | 0.0% | 0.14p | 0.15p | 0.13p | 20,032,318 | |
| 0.14p | -0.005 | -3.4% | 0.145p | 0.15p | 0.13p | 2,786,069 | |
| 0.145p | -0.01 | -6.5% | 0.155p | 0.16p | 0.14p | 16,976,046 | |
| 0.155p | 0.00 | 0.0% | 0.155p | 0.16p | 0.15p | 1,623,658 | |
| 0.155p | 0.00 | 0.0% | 0.155p | 0.16p | 0.15p | 729,861 | |
| 0.155p | 0.00 | 0.0% | 0.155p | 0.16p | 0.15p | 14,692 | |
| 0.155p | 0.00 | 0.0% | 0.155p | 0.16p | 0.15p | 183,400 | |
| 0.155p | 0.00 | 0.0% | 0.155p | 0.16p | 0.155p | 251,861 | |
| 0.155p | -0.005 | -3.1% | 0.16p | 0.17p | 0.146p | 1,624,822 | |
| 0.16p | 0.00 | 0.0% | 0.16p | 0.17p | 0.15p | 149,147 |
Splits
5 splits since 2003 · LSE:VAL · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-125 | Consolidation | |
| 1-for-125 | Consolidation | |
| 1-for-30 | Consolidation | |
| 1-for-2 | Consolidation | |
| 1-for-100 | Consolidation |
- Ticker
- Frankfurt:EAJF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 21, 2026
Update on Ambrose Healthcare shareholding
Calls
Replays
ValiRx (LSE:VAL) — Investor update presentation
Tue, Sep 28, 2021 · 8:00 AM ET
Watch Transcript
Latest news
Update on Ambrose Healthcare shareholding
Oct 21, 2026
Closed 0.145p (-9.4%) on Oct 21, 2026
Half-year Financial Report
Sep 15, 2026
Closed 0.145p (0.0%) on Sep 15, 2026
Cytolytix Patent Update
Aug 10, 2026
Closed 0.16p (0.0%) on Aug 10, 2026
Result of AGM, Warrants & Directorate Change
Jul 17, 2026
Closed 0.16p (0.0%) on Jul 17, 2026
Conclusion of Evaluation with University of Dundee
Jun 22, 2026
Closed 0.17p (-8.1%) on Jun 22, 2026
Conclusion of Evaluation with Stingray
Jun 2, 2026
Closed 0.19p (-2.6%) on Jun 2, 2026
ValiRx Exercises Option on Evaluation Asset
Jun 1, 2026
Closed 0.195p (0.0%) on Jun 1, 2026
Cytolytix Patent Granted
May 27, 2026
Closed 0.20p (+2.6%) on May 27, 2026
Result of Oversubscribed WRAP Retail Offer
May 21, 2026
Closed 0.195p (+2.6%) on May 21, 2026
WRAP Retail Offer for up to £150,000
May 18, 2026
Closed 0.195p (-2.5%) on May 18, 2026
Financings
Private placement of placing shares with fundraising warrants
Nov 20, 2025 · US$964,784
Closed: £740,000 raised · GBX 0.25 a share · Warrants at GBX 0.5 for 36 months · SP Angel Corporate Finance LLP +2
Dealers: SP Angel Corporate Finance LLP (lead), Shard (co-lead), Shard Capital Partners LLP
Buyers: Mark Eccleston (36,000,000 new ordinary shares; 7.91% of enlarged share capital)
Insiders: Directors Mark Eccleston (36,000,000 shares), Cathy Tralau-Stewart, Gerry Desler and Martin Gouldstone (1,200,000 each) bought 39,600,000 new shares in total
Use of proceeds: R&D on the collaborative pipeline, preclinical development of Cytolytix and VAL201 2.0, and operating costs
Announced Oct 30, 2025 · Update Nov 4, 2025 · Closed Nov 20, 2025
Private placement of subscription shares with fundraising warrants
Nov 20, 2025 · US$13,038
Closed: £10,000 raised · GBX 0.25 a share
Buyers: Cathy Tralau-Stewart (1,200,000 New Ordinary Shares); Gerry Desler (1,200,000 New Ordinary Shares); Martin Gouldstone (1,200,000 New Ordinary Shares)
Insiders: Directors and persons closely associated subscribed directly; aggregate director participation in the Fundraising is £100,000
Announced Oct 30, 2025 · Update Nov 4, 2025 · Closed Nov 20, 2025
WRAP Retail Offer shares with warrants
Nov 20, 2025 · US$198,172
Closed: £152,000 raised · GBX 0.25 a share · 1 warrant at GBX 0.5 for 36 months · Winterflood Securities Limited
Dealers: Winterflood Securities Limited
Announced Oct 30, 2025 · Update Oct 30, 2025 · Update Nov 4, 2025 · Closed Nov 20, 2025
Broker Offer Shares
Dec 10, 2024 · US$318,892
Update: £250,000 · GBX 0.65 a share · 1 warrant at GBX 1.3 for 36 months · Shard Capital Partners LLP
Dealers: Shard Capital Partners LLP (lead)
Buyers: Mark Eccleston (3,076,923 Broker Offer Shares)
Insiders: CEO Mark Eccleston subscribed for a further 3,076,923 Broker Offer Shares under the Broker Offer, in addition to his participation in the Subscription
Private placement of new ordinary shares with warrants
Dec 9, 2024 · US$1.51M
Announced: £1.18M · GBX 0.65 a share · 1 warrant at GBX 1.3 for 36 months · Shard Capital Partners LLP
Dealers: Shard Capital Partners LLP (lead)
Use of proceeds: R&D on CytoLytix (formulation, preclinical and combination testing, more cancer types), new evaluation projects, next in-licence and operating costs
Private placement of new ordinary shares with warrants (Director/PDMR Subscription)
Dec 9, 2024 · US$178,800
Announced: £140,000 · GBX 0.65 a share · 1 warrant at GBX 1.3 for 36 months
Buyers: Mark Eccleston (17,692,307 Subscription Shares (including OncoLytika Ltd and his partner); 5.25% of enlarged share capital); Adrian de Courcey (1,538,461 Subscription Shares); Cathy Tralau-Stewart (769,231 Subscription Shares); Gerry Desler (769,231 Subscription Shares); Martin Gouldstone (769,231 Subscription Shares)
Insiders: Directors and persons closely associated with them subscribed for 21,538,461 shares (£140,000); a related party transaction under AIM Rule 13
Decks
Investor Presentation (November 2022)
Investor deck · 13 slides · November 2022
Shareholder Meeting (June 2022)
Shareholder meeting · 28 slides · Jun 30, 2022
Investor Presentation (April 2022)
Investor deck · 17 slides · April 2022
Technical Presentation (March 2021)
Technical · 12 slides · Mar 22, 2021
ValiRx PLC on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 450 in all · newest Oct 21, 2026 · oldest 2000
- Calls
- 1 call with a replay · 1 with a transcript · latest Sep 28, 2021
- Decks
- 4 decks · latest November 2022
Where ValiRx PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:VAL · Home listing | LSE | United Kingdom | GBX |
| LS Exchange:A2P1SH | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2P1SH | Lang & Schwarz | Germany | EUR |
| Frankfurt:EAJF · This page | Frankfurt | Germany | EUR |
| Stuttgart:EAJF | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about ValiRx PLC.